Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why measure blood barbiturates?

E Simpson1, M Stewart

  • 1Department of Clinical Chemistry, Ninewells Hospital and Medical School, Ninewells, Dundee.

Annals of Clinical Biochemistry
|July 1, 1975
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benefits of Integrated Social Care in the Management of Patients With Inborn Errors of Metabolism.

JIMD reports·2025
Same author

Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Sickle cell bone disease and response to intravenous bisphosphonates in children.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

User attitudes towards virtual home assessment technologies.

Journal of medical engineering & technology·2022
Same author

Online KidClot education for patients and families initiating warfarin therapy: The eKITE study.

Thrombosis research·2022
Same author

Pioneering global best practices in atopic dermatitis: results from the atopic dermatitis quality of care initiative.

Clinical and experimental dermatology·2021
Same journal

Routine laboratory triage for NT-proBNP elevation may reflect cardiorenal frailty as much as heart failure specificity.

Annals of clinical biochemistry·2026
Same journal

From interpretable NT-proBNP prediction to equitable laboratory stewardship.

Annals of clinical biochemistry·2026
Same journal

Serum Sclerostin Levels in Children with Osteogenesis Imperfecta.

Annals of clinical biochemistry·2026
Same journal

Population-Specific HOMA-IR Reference Ranges in Iraq: Defining Insulin Sensitivity in a Middle Eastern Cohort.

Annals of clinical biochemistry·2026
Same journal

Optimizing Laboratory Quality with Sigma Metrics: Application of CLIA 2024 Total Allowable Error Guidelines.

Annals of clinical biochemistry·2026
Same journal

Suspected thermal amplitude of cryoglobulin likely more clinically significant than size detected: A case report.

Annals of clinical biochemistry·2026
See all related articles

Blood phenobarbitone levels may not reliably track patient recovery from poisoning. Even with clinical improvement, levels can rise due to treatment, questioning the utility of single blood samples in managing poisoned patients.

Area of Science:

  • Clinical Pharmacology
  • Toxicology
  • Pharmacokinetics

Background:

  • Phenobarbitone is a common anticonvulsant and sedative.
  • Accurate monitoring of drug levels is crucial for effective patient management, especially in overdose cases.
  • Clinical assessment often guides treatment decisions in toxicology.

Observation:

  • Phenobarbitone blood levels can increase during active treatment, even when the patient is clinically improving.
  • Three case studies illustrate the discrepancy between phenobarbitone levels and clinical status.
  • The analytical methods for measuring phenobarbitone are generally reliable.

Findings:

  • A single blood specimen poorly represents the overall drug distribution and elimination in the body.
  • The correlation between phenobarbitone concentration and clinical condition is often poor.

Related Experiment Videos

  • Observed increases in blood levels may reflect treatment effects rather than worsening toxicity.

    • Implications:

    • Relying solely on phenobarbitone blood levels for management decisions in poisoned patients can be misleading.
    • Clinical evaluation remains paramount in guiding treatment for phenobarbitone poisoning.
    • Further research into more representative methods for assessing drug disposition in poisoned patients is warranted.